AGNISTA THERAPEUTICS Trademark

Trademark Overview


On Tuesday, November 10, 2020, a trademark application was filed for AGNISTA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AGNISTA THERAPEUTICS trademark a serial number of 90311140. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Agnista Therapeutics Inc.. The AGNISTA THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Biological preparations for the treatment of cancer; Biological preparations for the treatment of inflammatory diseases, disorders and conditions; Biological preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases, disorders and conditions

Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies

Clinical research in the field of immune related diseases, disorders and conditions; Clinical research in the field of tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of inflammatory diseases, disorders and conditions; Development of pharmaceutical preparations and medicines; Medical research; Medical and scientific research in the field of inflammatory diseases and cancer treatment and diagnosis; Medical and scientific research in the field of immune related diseases, disorders and conditions; Medical and scientific research in the field of tumors, malignancies, and related diseases, disorders and conditions; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development
agnista therapeutics

General Information


Serial Number90311140
Word MarkAGNISTA THERAPEUTICS
Filing DateTuesday, November 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesBiological preparations for the treatment of cancer; Biological preparations for the treatment of inflammatory diseases, disorders and conditions; Biological preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases, disorders and conditions
Goods and ServicesLicensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesClinical research in the field of immune related diseases, disorders and conditions; Clinical research in the field of tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of inflammatory diseases, disorders and conditions; Development of pharmaceutical preparations and medicines; Medical research; Medical and scientific research in the field of inflammatory diseases and cancer treatment and diagnosis; Medical and scientific research in the field of immune related diseases, disorders and conditions; Medical and scientific research in the field of tumors, malignancies, and related diseases, disorders and conditions; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgnista Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Party NameAgnista Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events


Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 19, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 19, 2021EXAMINERS AMENDMENT -WRITTEN
Saturday, April 17, 2021ASSIGNED TO EXAMINER
Sunday, January 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 13, 2020NEW APPLICATION ENTERED IN TRAM